Biotechnology
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

$385.6M

Market Cap • 12/26/2024

2019

(5 years)
Founded

2022

(2 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Cambridge

Headquarters • Massachusetts